Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

BG Medicine Inc.

TRADE

NASDAQ: BGMDHealthcare / Medical Laboratories & Research / USA
0.04800.00Vol 17 0501Y Perf -4.00%
Jun 22nd, 2018 12:19
BID0.00 ASK0.00
Open0.04 Previous Close0.048
Pre-Market- After-Trading-
 - -%  - -%
Target Price
- 
Analyst Rating
— 0.00
Potencial %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)1 
Earnings Rating
Price Range Ratio 52wk %
40.00 
Earnings Date

Today's Price Range

0.040.048

 

52wk Range

0.020.09

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Month
20.00%
3 Months
-20.40%
6 Months
11.37%
1 Year
-4.00%
3 Years
-98.20%
5 Years
-99.12%

Quotes

Name / TickerPriceChg.Chg.%
BGMD0.0480.00000.00
AAPL184.92-0.5400-0.29
GOOG1 155.48-2.1800-0.19
MSFT100.41-0.7300-0.72
XOM81.381.69002.12
WFC53.94-0.4300-0.79
JNJ122.841.39001.14
FB201.740.24000.12
GE13.050.29002.27
JPM105.75-1.7600-1.64
...

TickerPriceChg.%52 Week High
KMX80.1912.8681.67
MRO21.487.8322.12
APC74.116.6974.72
PCG42.925.9071.57
PDCO24.625.7648.29
NFX30.755.2035.20
DVN43.285.1845.16
FTI32.345.1435.00
HES64.574.6365.89
PXD185.654.29213.40
XEC97.694.18130.16
COP67.784.1071.71
SWN5.473.806.72
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 1.40
Current Ratio 1.70
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -32.40
Leverage Ratio -
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-
EBITDA Margin-
Pre-tax Profit Margin-338.90
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 43.62
PS Ratios -
Price to Cash Flow -
Price to Free Cash Flow -
Cash Flow Per Share -0.32
Price to Tangible Book-0.17
Book Value per Share-0.17
Enterprise Value (in ths.)341
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)364.30
ROE last 12 Months 980.69
Return on Assets (5Y Avg) -393.05
ROA last 12 Months -189.02
Return on Capital (5Y Avg) -
ROC last 12 Months -
Return on invested Capital Q -
Return on invested Capital Y-
Assets Turnover-
Receivables Turnover-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)-
Revenue per Share -
Revenue Growth 3 Years -16.18
Revenue Growth 5 Years -4.57
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q03 2015--0.27-
Q02 2015--0.23-
Q01 2015--0.16-
Q04 2014--0.16-
Q03 2014--0.28-
Q02 2014-0.24-0.240.00
Q01 2014--0.32-
Q04 2013--0.06-
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date3rd Jan 2017
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume17 050
Shares Outstanding (in ths.)11 370
Trades Count5
Dollar Volume691
Avg. Volume13 958
Avg. Weekly Volume15 730
Avg. Monthly Volume16 068
Avg. Quarterly Volume15 355

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

67%33%

Bearish Bullish

57%43%

Bearish Bullish

62%38%

Bearish Bullish

64%36%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0 (0.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
1 (100.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Rating--Hold
3.00

There are no comments yet.

News

x